Clinical value of early viscoelastometric point-of-care testing during postpartum haemorrhage for the prediction of severity of bleeding: A multicentre prospective cohort study in the Netherlands
We conducted an in vitro study to explore whether substitution with fibrin-stabilizing factor XIII (FXIII) combined with fibrinogen promotes further improvement of clot formation, and whether fibrinogen administration as concentrate or fresh frozen plasma (FFP) results in comparable effects.
Congenital dysfibrinogenemia is a qualitative congenital fibrinogen disorder characterized by normal antigen levels of a dysfunctional fibrinogen. The diagnosis is usually based on discrepancies between fibrinogen activity and...
Clinical Practice Guideline for the diagnosis, staging, risk assessment, and treatment of different cancer types during pregnancy; obstetric care and fetal follow-up; pregnancy in cancer survivors; and fertility preservation...
Afibrinogenemia is a rare hereditary coagulation disorder characterized by a propensity toward bleeding. A 21-year-old Hispanic woman with afibrinogenemia developed ascites, a distended abdomen, an enlarged liver...
Take a look into hemostatic characteristics during pediatric liver transplantation using the thromboelastometry (ROTEMĀ®) test.
Hereditary fibrinogen abnormalities comprise two classes of plasma fibrinogen defects: Type I, afibrinogenemia or hypofibrinogenemia, which has absent or low plasma fibrinogen antigen levels (quantitative fibrinogen deficiencies)...
Cardiac surgery patients use 10%-25% of the blood products transfused annually in the United States. The transfusion of red blood cells or blood products has been the subject of intense scrutiny over the past 10 years.
Varicella, the primary infection with varicella-zoster virus (VZV; human herpesvirus 3), in pregnancy may cause maternal mortality or serious morbidity. It may also cause fetal varicella syndrome (FVS) and varicella infection of the newborn...
Since the previous version of these Guidelines was published in 2012, new evidence has accumulated, particularly on diagnostic techniques, risk assessment, and the use of cardiovascular drugs. This made a revision of the recommendations necessary.